Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer

BACKGROUND: Small cell lung cancer (SCLC) and high-grade extrapulmonary neuroendocrine carcinomas (EPNEC) share similar histopathological features and treatment, but outcomes may differ. We evaluated in our study the expression of biomarkers associated with response rate (RR) to chemotherapy and ove...

Descripción completa

Detalles Bibliográficos
Autores principales: de M Rêgo, Juliana Florinda, de Medeiros, Raphael Salles Scortegagna, Braghiroli, Maria Ignez, Galvão, Breno, Neto, João Evangelista Bezerra, Munhoz, Rodrigo Ramella, Guerra, Juliana, Nonogaki, Suely, Kimura, Lidia, Pfiffer, Tulio Eduardo, de Castro, Gilberto, Hoff, Paulo Marcelo, Filho, Duilio Rocha, Costa, Frederico Perego, Riechelmann, Rachel P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2017
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5606295/
https://www.ncbi.nlm.nih.gov/pubmed/28955403
http://dx.doi.org/10.3332/ecancer.2017.767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5606295/
https://www.ncbi.nlm.nih.gov/pubmed/28955403
http://dx.doi.org/10.3332/ecancer.2017.767

Ejemplares similares